Sun 5 Sep 2010
Histogen Inc. Makes Headway in Pursuit of a Revolutionary Hair Loss Treatment
Category: Hair Cloning (Multiplication) , Hair Loss Blog , Hair Loss News , New Advances
With millions of men and women worldwide anxiously awaiting a hair loss cure, the first to market with a viable solution will no doubt reap huge rewards. Today, the greatest hope for such a cure may lie in stem cell research. Virtually unheard of only a few years ago outside of the medical field, stem cells have now become a household term. Promising to do everything from regrowing limbs to curing disease, stems cells may also provide the key to hair multiplication (HM).
With an eye toward developing such revolutionary treatments, Histogen Inc. opened its doors in 2007. Histogen is a regenerative medicine company that has been developing a series of products based on proprietary bioreactors (systems that support a biologically active environment) that mimic the embryonic environment but do not contain embryonic stem cells or animal components of any kind. This is good news because it avoids the controversy surrounding embryonic stem cell research that has caused periodic disruptions in government funding.
While there are a number of products in development at Histogen, the one that is of most interest to hair loss sufferers is their Hair Stimulating Complex (HSC). Currently being developed and evaluated as an injectable for hair growth, a single injection applied to one area of the balding scalp is reported to produce a 20% increase in terminal hairs that are expected to then grow for a period of time equal the duration of the patient’s original hair. In other words, if the patient lost his original hair after 30 years, the newly formed hair follicles should also last for 30 years.










